French biotech Abionyx Pharma will treat a fourth patient with its rare kidney disease candidate CER-001, following a compassionate access authorization (CAA). 11 July 2023
UK biopharma Arecor Therapeutics has entered into an agreement with an unnamed ‘leading biopharmaceutical company’ to support the ongoing development of a biosi 5 July 2023
British antibody-drug conjugate (ADC) company Pheon Therapeutics has inked an exclusive license agreement with China’s Biocytogen Pharmaceuticals. 5 July 2023
Dutch gene therapy company uniQure has appointed Walid Abi-Saab as chief medical officer, replacing Ricardo Dolmetsch, who will become president and chief scien 26 June 2023
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.